These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29181453)

  • 1. Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries.
    Seale AC; Hutchison C; Fernandes S; Stoesser N; Kelly H; Lowe B; Turner P; Hanson K; Chandler CIR; Goodman C; Stabler RA; Scott JAG
    Wellcome Open Res; 2017; 2():91. PubMed ID: 29181453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a Sentinel Laboratory-Based Antimicrobial Resistance Surveillance Network in Ethiopia.
    Hazim C; Abubeker Ibrahim R; Westercamp M; Belete GA; Amare Kibret B; Kanter T; Yimer G; Adem TS; Stevenson KB; Urrego M; Kale KN; Omondi MW; VanderEnde D; Park BJ; Parsons MMB; Gallagher KM
    Health Secur; 2018; 16(S1):S30-S36. PubMed ID: 30480505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.
    Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMR Surveillance in low and middle-income settings - A roadmap for participation in the Global Antimicrobial Surveillance System (GLASS).
    Seale AC; Gordon NC; Islam J; Peacock SJ; Scott JAG
    Wellcome Open Res; 2017; 2():92. PubMed ID: 29062918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.
    Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C
    Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.
    Lim C; Ashley EA; Hamers RL; Turner P; Kesteman T; Akech S; Corso A; Mayxay M; Okeke IN; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Infect; 2021 Oct; 27(10):1391-1399. PubMed ID: 34111583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial stewardship: can we add pharmacovigilance networks to the toolbox?
    Habarugira JMV; Figueras A
    Eur J Clin Pharmacol; 2021 May; 77(5):787-790. PubMed ID: 33196869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The barriers and facilitators of implementing a national laboratory-based AMR surveillance system in Cambodia: key informants' perspectives and assessments of microbiology laboratories.
    Mao S; Soputhy C; Lay S; Jacobs J; Ku GM; Chau D; Chhea C; Ir P
    Front Public Health; 2023; 11():1332423. PubMed ID: 38179556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global antimicrobial resistance: a system-wide comprehensive investigation using the Global One Health Index.
    Zhou N; Cheng Z; Zhang X; Lv C; Guo C; Liu H; Dong K; Zhang Y; Liu C; Chang YF; Chen S; Guo X; Zhou XN; Li M; Zhu Y
    Infect Dis Poverty; 2022 Aug; 11(1):92. PubMed ID: 35996187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening.
    Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global geographic trends in antimicrobial resistance: the role of international travel.
    Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory informatics capacity for effective antimicrobial resistance surveillance in resource-limited settings.
    Turner P; Rupali P; Opintan JA; Jaoko W; Feasey NA; Peacock SJ; Ashley EA
    Lancet Infect Dis; 2021 Jun; 21(6):e170-e174. PubMed ID: 33865461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial use and antimicrobial resistance trends in Canada: 2014.
    Ebrahim M; Gravel D; Thabet C; Abdesselam K; Paramalingam S; Hyson C
    Can Commun Dis Rep; 2016 Nov; 42(11):227-231. PubMed ID: 29769991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance surveillance in Ethiopia: Implementation experiences and lessons learned.
    Ibrahim RA; Teshal AM; Dinku SF; Abera NA; Negeri AA; Desta FG; Seyum ET; Gemeda AW; Keficho WM
    Afr J Lab Med; 2018; 7(2):770. PubMed ID: 30568898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening antimicrobial resistance surveillance systems: a scoping review.
    Do PC; Assefa YA; Batikawai SM; Reid SA
    BMC Infect Dis; 2023 Sep; 23(1):593. PubMed ID: 37697310
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.